-0.13 | -5.33%
| Price and Volume | |
|---|---|
| Recent Price | 2.44 |
| 52 Week High | 13.10 |
| 52 Week Low | 1.78 |
| Avg. Daily Vol. (Mil) | 0.44 |
| Beta (3 year) | 2.00 |
| Share Related Items | |
| Mkt Cap (Mil) | 126.00 |
| Shares Out (Mil) | 51.64 |
| Float (Mil) | 37.68 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 6.20 |
| Current Ratio | 6.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 9.80 |
| Price/Sales | 10.08 |
| Price/Book | 3.32 |
| Price/Cash Flow | 8.50 |
| Per Share Data | |
| Earnings | 0.25 |
| Sales | 0.24 |
| Book Value | 0.73 |
| Cash Flow | 0.29 |
| Business Summary | |
|---|---|
| SIGA Technologies, Inc. is a biotechnology Company, which designs and develops novel countermeasures to prevent and treat serious infectious diseases, with an emphasis on biological warfare defense. | |
| General Information | |
| 35 East 62nd Street
New York, NY 10065 |
|
| www.siga.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 68 | |
| CEO: Dr. Eric A. Rose, M.D. | |
| Short Interest | |
| Current Month (Mil) | 7.66 |
| Previous Month (Mil) | 7.65 |
| Short Interest Ratio (Days) | 20.70 |
| Management Effectiveness | |
| Return on Equity | 37.50 |
| Return on Assets | 16.00 |
| Return on Investments | 37.50 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,415.09 | 1,315.24 | 2,828.64 | 16.32 |
Oil *
103.42
|
|
DOWN
165.60 |
DOWN
17.18 |
DOWN
42.35 |
DOWN
0.99 |
10 Yr
1.63%
SPDR Gold
151.34
|
|
-1.32%
|
-1.29%
|
-1.48%
|
-5.72%
|
Data delayed 20 minutes |
Connect with TheStreet